Back to RTW Investments, LP RTW Investments, LP

MLTX

9 quarters

Position history for RTW Investments, LPRTW Investments, LP's holdings in MoonLake Immunotherapeutics

No. RTW Investments exited its MLTX (MoonLake Immunotherapeutics) position in Q3 2025. Its Q2 2025 13F listed 741,090 shares worth $35M. RTW Investments first reported MLTX in Q2 2022 and held it in 7 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$2.6M

Total Shares Change

-500,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$6.24
0
2025-Q2
New
741,090
-
$35M0.5%$47.52
48
2023-Q4
Exited
0
-100.0%
$00.0%$60.39
0
2023-Q3
Unchanged
500,000
0.0%
$28.5M0.6%$57.00
0
2023-Q2
Unchanged
500,000
0.0%
$25.5M0.5%$51.08
0
2023-Q1
Unchanged
500,000
0.0%
$10.7M0.2%$21.85
0
2022-Q4
Unchanged
500,000
0.0%
$5.3M0.1%$10.50
0
2022-Q3
Unchanged
500,000
0.0%
$3.9M0.1%$7.98
0
2022-Q2
New
500,000
-
$2.6M0.1%$5.00
36

Other major holders of MLTX: FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used